Caspase-8 in cancer biology and therapy

Simone Fulda1

  • 1University Children's Hospital, Ulm, Germany. simone.fulda@uniklinik-ulm.de

Cancer Letters
|December 30, 2008
PubMed

Insights

Caspase-8 is crucial for programmed cell death (apoptosis) and its dysfunction is linked to cancer progression and treatment resistance. Restoring caspase-8 function offers a promising therapeutic strategy for overcoming cancer resistance.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Caspase-8 is a key protease regulating programmed cell death (apoptosis) via the extrinsic pathway.
  • Dysregulation of caspase-8 expression or function is implicated in various human diseases.
  • Caspase-8 inactivation is observed in many cancers, contributing to tumor progression and therapeutic resistance.

Purpose of the Study:

  • To highlight the critical role of caspase-8 in apoptosis regulation.
  • To underscore the significance of caspase-8 dysfunction in human cancers.
  • To propose caspase-8 as a therapeutic target for overcoming cancer resistance.

Main Methods:

  • Literature review on caspase-8 function and its role in apoptosis.
  • Analysis of studies linking caspase-8 inactivation to cancer development and progression.
  • Exploration of therapeutic strategies targeting caspase-8 for cancer treatment.

Main Results:

  • Caspase-8 is essential for initiating apoptosis through the death receptor pathway.
  • Inactivation of caspase-8 promotes tumor growth and resistance to cancer therapies.
  • Restoring functional caspase-8 can re-establish apoptotic pathways in cancer cells.

Conclusions:

  • Caspase-8 is a vital regulator of apoptosis and a critical factor in cancer biology.
  • Targeting caspase-8 presents a promising approach to sensitize tumors to existing treatments and overcome resistance.
  • Further research into caspase-8 modulation could lead to novel cancer therapies.

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...